{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:36:53Z","timestamp":1772491013155,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.yebeh.2020.107127","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T08:11:14Z","timestamp":1589530274000},"page":"107127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity"],"prefix":"10.1016","volume":"109","author":[{"given":"Jerzy P.","family":"Szaflarski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulette","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Varner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107127_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107127_bb0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1684\/epd.2012.0514","article-title":"Clinical trials in acute repetitive seizures and status epilepticus","volume":"14","author":"Shorvon","year":"2012","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2020.107127_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","article-title":"Seizure clusters: characteristics and treatment","volume":"28","author":"Haut","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2020.107127_bb0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01376517-199908000-00004","article-title":"New therapies in the management of acute or cluster seizures and seizure emergencies","volume":"31","author":"Shafer","year":"1999","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.yebeh.2020.107127_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2005.08.018","article-title":"Seizure clustering","volume":"8","author":"Haut","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107127_bb0030","author":"Briviact\u00ae (brivaracetam) Summary of Product Characteristics"},{"key":"10.1016\/j.yebeh.2020.107127_bb0035","author":"Briviact\u00ae (brivaracetam) Prescribing Information"},{"key":"10.1016\/j.yebeh.2020.107127_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107127_bb0045","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/epi.14701","article-title":"A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers","volume":"60","author":"Finnema","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cpdd.275","article-title":"Relative bioavailability and bioequivalence of brivaracetam 10 mg\/mL oral solution and 50-mg film-coated tablet","volume":"6","author":"Otoul","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.yebeh.2020.107127_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1528-1167.2010.02746.x","article-title":"Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam","volume":"52","author":"Meador","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0060","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/epi.13409","article-title":"Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy","volume":"57","author":"Klein","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","article-title":"Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2020.107127_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11940-016-0401-x","article-title":"The role of benzodiazepines in the treatment of epilepsy","volume":"18","author":"Ochoa","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.yebeh.2020.107127_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2016.07.018","article-title":"Benzodiazepine use in seizure emergencies: a systematic review","volume":"63","author":"Haut","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107127_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2344\/16-00019.1","article-title":"Benzodiazepine allergy with anesthesia administration: a review of current literature","volume":"63","author":"Haybarger","year":"2016","journal-title":"Anesth Prog"},{"key":"10.1016\/j.yebeh.2020.107127_bb0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000053748.83309.28","article-title":"Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoring","volume":"60","author":"Rose","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107127_bb0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2018.09.035","article-title":"Prevalence and predictors of seizure clusters: a prospective observational study of adult patients with epilepsy","volume":"88","author":"Detyniecki","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107127_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2017.05.001","article-title":"Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study","volume":"49","author":"Gujjar","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107127_bb0110","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/archneur.59.12.1915","article-title":"Rectal diazepam gel for treatment of acute repetitive seizures in adults","volume":"59","author":"Cereghino","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2020.107127_bb0115","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1528-1157.1999.tb02047.x","article-title":"An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance","volume":"40","author":"Mitchell","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0120","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/epi.12373","article-title":"A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures","volume":"54","author":"Abou-Khalil","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107127_bb0125","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/epi.12685","article-title":"Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures","volume":"55","author":"Rogin","year":"2014","journal-title":"Epilepsia"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:32:17Z","timestamp":1761503537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020303061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"alternative-id":["S1525505020303061"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107127","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107127"}}